The report highlights a few examples in 2022 of how CERN’s technology and know-how, paired with the expertise of our partners, can drive innovation and progress for the benefit of society as a whole.

This funding supports the commercialization of Terapet’s first product, Qualγscan and the development of new nuclear imaging products.

CERN, CHUV and THERYQ have signed an agreement for the development of a revolutionary FLASH radiotherapy device

A novel proton accelerator for cancer treatment, based on CERN technology, is getting ready to receive its first patients in the United Kingdom